-
1
-
-
69049083492
-
Denosumab for prevention of fractures in postmenopausal women with osteoporosis
-
Cummings S.R., Martin J.S., McClung M.R., Siris E.S., Eastell R., Reid I.R., et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009, 361:756-765.
-
(2009)
N Engl J Med
, vol.361
, pp. 756-765
-
-
Cummings, S.R.1
Martin, J.S.2
McClung, M.R.3
Siris, E.S.4
Eastell, R.5
Reid, I.R.6
-
2
-
-
0003458828
-
-
Oxford University Press, New-York
-
Drummond M., Sculpher M., O'Brien B., Stoddart G., Torrance G. Methods for the economic evaluation of health care programmes 2007, Oxford University Press, New-York. 3th edition.
-
(2007)
Methods for the economic evaluation of health care programmes
-
-
Drummond, M.1
Sculpher, M.2
O'Brien, B.3
Stoddart, G.4
Torrance, G.5
-
5
-
-
66249113859
-
Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests
-
Cleemput I., van Wilder P., Huybrechts M., Vrijens F. Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests. Value Health 2009, 12:441-449.
-
(2009)
Value Health
, vol.12
, pp. 441-449
-
-
Cleemput, I.1
van Wilder, P.2
Huybrechts, M.3
Vrijens, F.4
-
6
-
-
33845367564
-
Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model
-
Zethraeus N., Borgstrom F., Strom O., Kanis J.A., Jonsson B. Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporos Int 2007, 18:9-23.
-
(2007)
Osteoporos Int
, vol.18
, pp. 9-23
-
-
Zethraeus, N.1
Borgstrom, F.2
Strom, O.3
Kanis, J.A.4
Jonsson, B.5
-
7
-
-
67649933646
-
Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis
-
Hiligsmann M., Ethgen O., Bruyere O., Richy F., Gathon H.J., Reginster J.Y. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 2009, 12:687-696.
-
(2009)
Value Health
, vol.12
, pp. 687-696
-
-
Hiligsmann, M.1
Ethgen, O.2
Bruyere, O.3
Richy, F.4
Gathon, H.J.5
Reginster, J.Y.6
-
8
-
-
57049160894
-
Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women
-
Hiligsmann M., Bruyere O., Ethgen O., Gathon H.J., Reginster J.Y. Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women. Bone 2008, 43:991-994.
-
(2008)
Bone
, vol.43
, pp. 991-994
-
-
Hiligsmann, M.1
Bruyere, O.2
Ethgen, O.3
Gathon, H.J.4
Reginster, J.Y.5
-
9
-
-
0034757430
-
Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategy
-
Reginster J.Y., Gillet P., Gosset C. Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategy. Bull World Health Organ 2001, 79:942-946.
-
(2001)
Bull World Health Organ
, vol.79
, pp. 942-946
-
-
Reginster, J.Y.1
Gillet, P.2
Gosset, C.3
-
10
-
-
85045798171
-
Treatment of established osteoporosis: a systematic review and cost-utility analysis
-
Kanis J.A., Brazier J.E., Stevenson M., Calvert N.W., Lloyd Jones M. Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 2002, 6:1-146.
-
(2002)
Health Technol Assess
, vol.6
, pp. 1-146
-
-
Kanis, J.A.1
Brazier, J.E.2
Stevenson, M.3
Calvert, N.W.4
Lloyd Jones, M.5
-
11
-
-
0034022318
-
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis
-
Klotzbuecher C.M., Ross P.D., Landsman P.B., Abbott T.A., Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000, 15:721-739.
-
(2000)
J Bone Miner Res
, vol.15
, pp. 721-739
-
-
Klotzbuecher, C.M.1
Ross, P.D.2
Landsman, P.B.3
Abbott, T.A.4
Berger, M.5
-
12
-
-
1642301168
-
Fracture risk following an osteoporotic fracture
-
Johnell O., Kanis J.A., Oden A., Sernbo I., Redlund-Johnell I., Petterson C., et al. Fracture risk following an osteoporotic fracture. Osteoporos Int 2004, 15:175-179.
-
(2004)
Osteoporos Int
, vol.15
, pp. 175-179
-
-
Johnell, O.1
Kanis, J.A.2
Oden, A.3
Sernbo, I.4
Redlund-Johnell, I.5
Petterson, C.6
-
13
-
-
3242728658
-
A meta-analysis of previous fracture and subsequent fracture risk
-
Kanis J.A., Johnell O., De Laet C., Johansson H., Oden A., Delmas P., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004, 35:375-382.
-
(2004)
Bone
, vol.35
, pp. 375-382
-
-
Kanis, J.A.1
Johnell, O.2
De Laet, C.3
Johansson, H.4
Oden, A.5
Delmas, P.6
-
14
-
-
77954761936
-
-
Institut National de Statistique. Démographie mathématique. Tables de mortalité 2006 et 2004-2006. Direction Générale Statistique et Information Economique. Belgium.
-
Institut National de Statistique. Démographie mathématique. Tables de mortalité 2006 et 2004-2006. Direction Générale Statistique et Information Economique. Belgium 2008.
-
(2008)
-
-
-
15
-
-
0031674655
-
Lifetime risk of hip fractures is underestimated
-
Oden A., Dawson A., Dere W., Johnell O., Jonsson B., Kanis J.A. Lifetime risk of hip fractures is underestimated. Osteoporos Int 1998, 8:599-603.
-
(1998)
Osteoporos Int
, vol.8
, pp. 599-603
-
-
Oden, A.1
Dawson, A.2
Dere, W.3
Johnell, O.4
Jonsson, B.5
Kanis, J.A.6
-
16
-
-
0033802496
-
Risk of mortality following clinical fractures
-
Cauley J.A., Thompson D.E., Ensrud K.C., Scott J.C., Black D. Risk of mortality following clinical fractures. Osteoporos Int 2000, 11:556-561.
-
(2000)
Osteoporos Int
, vol.11
, pp. 556-561
-
-
Cauley, J.A.1
Thompson, D.E.2
Ensrud, K.C.3
Scott, J.C.4
Black, D.5
-
17
-
-
1342268230
-
Mortality after osteoporotic fractures
-
Johnell O., Kanis J.A., Oden A., Sernbo I., Redlund-Johnell I., Petterson C., et al. Mortality after osteoporotic fractures. Osteoporos Int 2004, 15:38-42.
-
(2004)
Osteoporos Int
, vol.15
, pp. 38-42
-
-
Johnell, O.1
Kanis, J.A.2
Oden, A.3
Sernbo, I.4
Redlund-Johnell, I.5
Petterson, C.6
-
18
-
-
1342289957
-
Excess mortality after hospitalisation for vertebral fracture
-
Kanis J.A., Oden A., Johnell O., De Laet C., Jonsson B. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 2004, 15:108-112.
-
(2004)
Osteoporos Int
, vol.15
, pp. 108-112
-
-
Kanis, J.A.1
Oden, A.2
Johnell, O.3
De Laet, C.4
Jonsson, B.5
-
19
-
-
1242335072
-
The components of excess mortality after hip fracture
-
Kanis J.A., Oden A., Johnell O., De Laet C., Jonsson B., Oglesby A.K. The components of excess mortality after hip fracture. Bone 2003, 32:468-473.
-
(2003)
Bone
, vol.32
, pp. 468-473
-
-
Kanis, J.A.1
Oden, A.2
Johnell, O.3
De Laet, C.4
Jonsson, B.5
Oglesby, A.K.6
-
20
-
-
0032899592
-
Direct costs of hip fractures in patients over 60years of age in Belgium
-
Reginster J.Y., Gillet P., Ben Sedrine W., Brands G., Ethgen O., de Froidmont C., et al. Direct costs of hip fractures in patients over 60years of age in Belgium. Pharmacoeconomics 1999, 15:507-514.
-
(1999)
Pharmacoeconomics
, vol.15
, pp. 507-514
-
-
Reginster, J.Y.1
Gillet, P.2
Ben Sedrine, W.3
Brands, G.4
Ethgen, O.5
de Froidmont, C.6
-
21
-
-
0033938154
-
Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group
-
Autier P., Haentjens P., Bentin J., Baillon J.M., Grivegnee A.R., Closon M.C., et al. Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group. Osteoporos Int 2000, 11:373-380.
-
(2000)
Osteoporos Int
, vol.11
, pp. 373-380
-
-
Autier, P.1
Haentjens, P.2
Bentin, J.3
Baillon, J.M.4
Grivegnee, A.R.5
Closon, M.C.6
-
22
-
-
33749023290
-
Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries
-
Bouee S., Lafuma A., Fagnani F., Meunier P.J., Reginster J.Y. Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int 2006, 26:1063-1072.
-
(2006)
Rheumatol Int
, vol.26
, pp. 1063-1072
-
-
Bouee, S.1
Lafuma, A.2
Fagnani, F.3
Meunier, P.J.4
Reginster, J.Y.5
-
23
-
-
0036245299
-
Direct medical costs attributable to osteoporotic fractures
-
Gabriel S.E., Tosteson A.N., Leibson C.L., Crowson C.S., Pond G.R., Hammond C.S., et al. Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 2002, 13:323-330.
-
(2002)
Osteoporos Int
, vol.13
, pp. 323-330
-
-
Gabriel, S.E.1
Tosteson, A.N.2
Leibson, C.L.3
Crowson, C.S.4
Pond, G.R.5
Hammond, C.S.6
-
24
-
-
0041705941
-
Cost-equivalence of different osteoporotic fractures
-
Melton L.J., Gabriel S.E., Crowson C.S., Tosteson A.N., Johnell O., Kanis J.A. Cost-equivalence of different osteoporotic fractures. Osteoporos Int 2003, 14:383-388.
-
(2003)
Osteoporos Int
, vol.14
, pp. 383-388
-
-
Melton, L.J.1
Gabriel, S.E.2
Crowson, C.S.3
Tosteson, A.N.4
Johnell, O.5
Kanis, J.A.6
-
25
-
-
43049083017
-
Utility values associated with osteoporotic fracture: a systematic review of the literature
-
Hiligsmann M., Ethgen O., Richy F., Reginster J.Y. Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int 2008, 82:288-292.
-
(2008)
Calcif Tissue Int
, vol.82
, pp. 288-292
-
-
Hiligsmann, M.1
Ethgen, O.2
Richy, F.3
Reginster, J.Y.4
-
26
-
-
0035698323
-
Impact of hip and vertebral fractures on quality-adjusted life years
-
Tosteson A.N., Gabriel S.E., Grove M.R., Moncur M.M., Kneeland T.S., Melton L.J. Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 2001, 12:1042-1049.
-
(2001)
Osteoporos Int
, vol.12
, pp. 1042-1049
-
-
Tosteson, A.N.1
Gabriel, S.E.2
Grove, M.R.3
Moncur, M.M.4
Kneeland, T.S.5
Melton, L.J.6
-
27
-
-
44649120398
-
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
-
Kanis J., Burlet N., Cooper C., Delmas P.D., Reginster J.Y., Borgstrom F., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008, 19:399-428.
-
(2008)
Osteoporos Int
, vol.19
, pp. 399-428
-
-
Kanis, J.1
Burlet, N.2
Cooper, C.3
Delmas, P.D.4
Reginster, J.Y.5
Borgstrom, F.6
-
28
-
-
0033755942
-
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
-
Kanis J.A., Johnell O., Oden A., Jonsson B., De Laet C., Dawson A. Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 2000, 27:585-590.
-
(2000)
Bone
, vol.27
, pp. 585-590
-
-
Kanis, J.A.1
Johnell, O.2
Oden, A.3
Jonsson, B.4
De Laet, C.5
Dawson, A.6
-
29
-
-
0031765564
-
Updated data on proximal femur bone mineral levels of US adults
-
Looker A.C., Wahner H.W., Dunn W.L., Calvo M.S., Harris T.B., Heyse S.P., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998, 8:468-489.
-
(1998)
Osteoporos Int
, vol.8
, pp. 468-489
-
-
Looker, A.C.1
Wahner, H.W.2
Dunn, W.L.3
Calvo, M.S.4
Harris, T.B.5
Heyse, S.P.6
-
30
-
-
10644229524
-
Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium
-
Boonen S., Kaufman J.M., Reginster J.Y., Devogelaer J.P. Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium. Osteoporos Int 2003, 14:110-115.
-
(2003)
Osteoporos Int
, vol.14
, pp. 110-115
-
-
Boonen, S.1
Kaufman, J.M.2
Reginster, J.Y.3
Devogelaer, J.P.4
-
31
-
-
0029986509
-
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
-
Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254-1259.
-
(1996)
BMJ
, vol.312
, pp. 1254-1259
-
-
Marshall, D.1
Johnell, O.2
Wedel, H.3
-
32
-
-
20844462737
-
Predictive value of BMD for hip and other fractures
-
Johnell O., Kanis J.A., Oden A., Johansson H., De Laet C., Delmas P., et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005, 20:1185-1194.
-
(2005)
J Bone Miner Res
, vol.20
, pp. 1185-1194
-
-
Johnell, O.1
Kanis, J.A.2
Oden, A.3
Johansson, H.4
De Laet, C.5
Delmas, P.6
-
33
-
-
52449112052
-
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial
-
Miller P.D., Bolognese M.A., Lewiecki E.M., McClung M.R., Ding B., Austin M., et al. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone 2008, 43:222-229.
-
(2008)
Bone
, vol.43
, pp. 222-229
-
-
Miller, P.D.1
Bolognese, M.A.2
Lewiecki, E.M.3
McClung, M.R.4
Ding, B.5
Austin, M.6
-
34
-
-
77954761120
-
Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass
-
Bone H., Bolognese M., Yuen D., Kendler D., Miller P., Yang Y., et al. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Bone Miner Res 2009, 24(Suppl 1).
-
(2009)
J Bone Miner Res
, vol.24
, Issue.SUPPL 1
-
-
Bone, H.1
Bolognese, M.2
Yuen, D.3
Kendler, D.4
Miller, P.5
Yang, Y.6
-
36
-
-
58149215739
-
An economic evaluation of quantitative ultrasonometry as pre-screening test for the identification of patients with osteoporosis
-
Hiligsmann M., Ethgen O., Bruyere O., Reginster J.Y. An economic evaluation of quantitative ultrasonometry as pre-screening test for the identification of patients with osteoporosis. Dis Manage Health Outcomes 2008, 16:429-438.
-
(2008)
Dis Manage Health Outcomes
, vol.16
, pp. 429-438
-
-
Hiligsmann, M.1
Ethgen, O.2
Bruyere, O.3
Reginster, J.Y.4
-
37
-
-
0034871011
-
A systematic review of the associations between dose regimens and medication compliance
-
Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001, 23:1296-1310.
-
(2001)
Clin Ther
, vol.23
, pp. 1296-1310
-
-
Claxton, A.J.1
Cramer, J.2
Pierce, C.3
-
38
-
-
34347406006
-
A systematic review of persistence and compliance with bisphosphonates for osteoporosis
-
Cramer J.A., Gold D.T., Silverman S.L., Lewiecki E.M. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007, 18:1023-1031.
-
(2007)
Osteoporos Int
, vol.18
, pp. 1023-1031
-
-
Cramer, J.A.1
Gold, D.T.2
Silverman, S.L.3
Lewiecki, E.M.4
-
39
-
-
43249095727
-
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
-
Rabenda V., Mertens R., Fabri V., Vanoverloop J., Sumkay F., Vannecke C., et al. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 2008, 19:811-818.
-
(2008)
Osteoporos Int
, vol.19
, pp. 811-818
-
-
Rabenda, V.1
Mertens, R.2
Fabri, V.3
Vanoverloop, J.4
Sumkay, F.5
Vannecke, C.6
-
40
-
-
72449152953
-
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women
-
Hiligsmann M., Bruyere O., Reginster J.Y. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women. Osteoporos Int 2010, 21:157-165.
-
(2010)
Osteoporos Int
, vol.21
, pp. 157-165
-
-
Hiligsmann, M.1
Bruyere, O.2
Reginster, J.Y.3
-
41
-
-
84857195304
-
-
Valeurs seuils pour le rapport coût-efficacité en soins de santé. Health Technology Assessment (HTA). Bruxelles: Centre fédéral d'expertise des soins de santé (KCE). KCE Reports 100B (D/2008/10.273/95).
-
Cleemput I, Neyt M, Thiry N, De Laet C, Leys M. Valeurs seuils pour le rapport coût-efficacité en soins de santé. Health Technology Assessment (HTA). Bruxelles: Centre fédéral d'expertise des soins de santé (KCE). KCE Reports 100B (D/2008/10.273/95).
-
-
-
Cleemput I1
Neyt M2
Thiry N3
De Laet C4
Leys, M.5
-
42
-
-
0035586112
-
NICE: faster access to modern treatments? Analysis of guidance on health technologies
-
Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. Br Med J 2001, 323:1300-1303.
-
(2001)
Br Med J
, vol.323
, pp. 1300-1303
-
-
Raftery, J.1
-
43
-
-
77954761079
-
-
National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 2008;4;437-47.
-
Tosetson AN, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, et al. National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 2008;4;437-47.
-
-
-
Tosetson AN1
Melton LJ2
Dawson-Hughes B3
Baim S4
Favus MJ5
Khosla S6
-
44
-
-
34248642474
-
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries-an economic evaluation based on the fracture intervention trial
-
Strom O., Borgstrom F., Sen S.S., Boonen S., Haentjens P., Johnell O., et al. Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries-an economic evaluation based on the fracture intervention trial. Osteoporos Int 2007, 18:1047-1061.
-
(2007)
Osteoporos Int
, vol.18
, pp. 1047-1061
-
-
Strom, O.1
Borgstrom, F.2
Sen, S.S.3
Boonen, S.4
Haentjens, P.5
Johnell, O.6
-
45
-
-
0032732055
-
Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?
-
Bombardier C., Maetzel A. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?. Ann Rheum Dis 1999, 58(Suppl 1):I82-I85.
-
(1999)
Ann Rheum Dis
, vol.58
, Issue.SUPPL 1
-
-
Bombardier, C.1
Maetzel, A.2
-
46
-
-
37349075476
-
The cost-effectiveness of alendronate in the management of osteoporosis
-
Kanis J.A., Adams J., Borgstrom F., Cooper C., Jonsson B., Preedy D., et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone 2008, 42:4-15.
-
(2008)
Bone
, vol.42
, pp. 4-15
-
-
Kanis, J.A.1
Adams, J.2
Borgstrom, F.3
Cooper, C.4
Jonsson, B.5
Preedy, D.6
-
47
-
-
43049175471
-
FRAX and the assessment of fracture probability in men and women from the UK
-
Kanis J.A., Johnell O., Oden A., Johansson H., McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19:385-397.
-
(2008)
Osteoporos Int
, vol.19
, pp. 385-397
-
-
Kanis, J.A.1
Johnell, O.2
Oden, A.3
Johansson, H.4
McCloskey, E.5
-
48
-
-
63449088093
-
FRAX and its applications to clinical practice
-
Kanis J.A., Oden A., Johansson H., Borgstrom F., Strom O., McCloskey E. FRAX and its applications to clinical practice. Bone 2009, 44:734-743.
-
(2009)
Bone
, vol.44
, pp. 734-743
-
-
Kanis, J.A.1
Oden, A.2
Johansson, H.3
Borgstrom, F.4
Strom, O.5
McCloskey, E.6
-
49
-
-
0004041788
-
-
Cambridge University Press, Cambridge
-
Hunink M., Glasziou P., Siegel J., Weeks J., Pliskin J., Elstein A., et al. Decision making in health and medicine: integrating evidence and values 2001, Cambridge University Press, Cambridge.
-
(2001)
Decision making in health and medicine: integrating evidence and values
-
-
Hunink, M.1
Glasziou, P.2
Siegel, J.3
Weeks, J.4
Pliskin, J.5
Elstein, A.6
-
50
-
-
66249124989
-
Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report
-
Drummond M., Barbieri M., Cook J., Glick H., Lis J., Malik F., et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health 2009, 12:409-418.
-
(2009)
Value Health
, vol.12
, pp. 409-418
-
-
Drummond, M.1
Barbieri, M.2
Cook, J.3
Glick, H.4
Lis, J.5
Malik, F.6
-
51
-
-
74249083881
-
Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75years
-
Hiligsmann M., Bruyere O., Reginster J.Y. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75years. Bone 2010, 46:440-446.
-
(2010)
Bone
, vol.46
, pp. 440-446
-
-
Hiligsmann, M.1
Bruyere, O.2
Reginster, J.Y.3
-
52
-
-
77954284615
-
Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence
-
[Electronic publication Ahead of Print]
-
Hiligsmann M., Gathon H.J., Bruyere O., Ethgen O., Rabenda V., Reginster J.Y. Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence. Value Health 2010, [Electronic publication Ahead of Print].
-
(2010)
Value Health
-
-
Hiligsmann, M.1
Gathon, H.J.2
Bruyere, O.3
Ethgen, O.4
Rabenda, V.5
Reginster, J.Y.6
|